ARCHIVES

Executive Committee, Board of Scientific Advisors concur.

This article is from The Cancer Letter archive.

Vol. 30 No. 01 | January 2, 2004

Download PDF Visit The Full Archive

Related Articles

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

April 9, 2010

ASCO Urges Steps to Eliminate Cancer Care Disparities

May 22, 2009

Bahama Government Closes Clinic “Immediately And Permanently” After AIDs Contamination Report

July 26, 1985

RFA On Natural Inhibitors Role In Prevention Released

April 2, 1982

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012